Axon Enterprise, Inc. (NASDAQ:AXON) Given Average Recommendation of “Buy” by Brokerages

Axon Enterprise, Inc. (NASDAQ:AXONGet Rating) has earned an average rating of “Buy” from the ten analysts that are currently covering the firm, MarketBeat reports. One research analyst has rated the stock with a hold rating, seven have given a buy rating and one has issued a strong buy rating on the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $193.38.

A number of research firms have weighed in on AXON. JPMorgan Chase & Co. raised Axon Enterprise from a “neutral” rating to an “overweight” rating and lowered their price objective for the stock from $222.00 to $192.00 in a research note on Friday, February 25th. Northland Securities reduced their target price on Axon Enterprise from $220.00 to $180.00 in a research report on Monday, February 28th. Needham & Company LLC reduced their target price on Axon Enterprise from $250.00 to $170.00 and set a “buy” rating on the stock in a research report on Friday, February 25th. Robert W. Baird restated a “buy” rating and issued a $175.00 target price on shares of Axon Enterprise in a research report on Friday, February 25th. Finally, Zacks Investment Research upgraded Axon Enterprise from a “sell” rating to a “hold” rating in a research report on Friday, March 4th.

NASDAQ AXON opened at $112.20 on Friday. The stock’s fifty day moving average is $129.57 and its two-hundred day moving average is $147.46. The firm has a market capitalization of $7.97 billion, a P/E ratio of -113.33 and a beta of 0.42. Axon Enterprise has a fifty-two week low of $111.38 and a fifty-two week high of $209.00.

Axon Enterprise (NASDAQ:AXONGet Rating) last released its quarterly earnings data on Thursday, February 24th. The biotechnology company reported ($0.19) earnings per share for the quarter, missing the Zacks’ consensus estimate of ($0.12) by ($0.07). The company had revenue of $217.58 million for the quarter, compared to analyst estimates of $202.65 million. Axon Enterprise had a negative return on equity of 5.62% and a negative net margin of 6.95%. The business’s quarterly revenue was down 3.8% on a year-over-year basis. During the same period last year, the firm posted $0.35 EPS. On average, equities research analysts predict that Axon Enterprise will post 0.83 earnings per share for the current fiscal year.

In related news, CFO Jawad A. Ahsan sold 4,840 shares of the business’s stock in a transaction on Tuesday, April 5th. The stock was sold at an average price of $141.17, for a total value of $683,262.80. Following the sale, the chief financial officer now owns 360,019 shares in the company, valued at approximately $50,823,882.23. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 6.90% of the stock is currently owned by insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in AXON. AE Wealth Management LLC acquired a new position in Axon Enterprise during the 3rd quarter worth $541,000. Treasurer of the State of North Carolina grew its stake in Axon Enterprise by 4.9% during the 3rd quarter. Treasurer of the State of North Carolina now owns 24,319 shares of the biotechnology company’s stock worth $4,256,000 after purchasing an additional 1,139 shares in the last quarter. Advisor Group Holdings Inc. grew its stake in Axon Enterprise by 3.9% during the 3rd quarter. Advisor Group Holdings Inc. now owns 17,889 shares of the biotechnology company’s stock worth $3,133,000 after purchasing an additional 668 shares in the last quarter. Griffin Asset Management Inc. acquired a new position in Axon Enterprise during the 3rd quarter worth $267,000. Finally, Oak Ridge Investments LLC acquired a new position in shares of Axon Enterprise during the 3rd quarter worth about $2,005,000. 75.47% of the stock is owned by hedge funds and other institutional investors.

Axon Enterprise Company Profile (Get Rating)

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, TASER, and Software and Sensors. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Read More

Analyst Recommendations for Axon Enterprise (NASDAQ:AXON)

Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.